Understanding the Emergency: When APS Becomes Catastrophic

Being in the Intensive Care Unit (ICU) because of a diagnosis you may have never heard of is terrifying. If your loved one is facing Catastrophic Antiphospholipid Syndrome (CAPS), it is important to know that what you are feeling is a natural response to an extreme medical event. CAPS is an ultra-rare, life-threatening complication occurring in approximately 1% of people with Antiphospholipid Syndrome (APS) ^[1][2]. It is a medical emergency that requires the highest level of hospital care and immediate intervention.

What is Catastrophic APS?

While standard APS can cause venous, arterial, and pregnancy-related complications over time, CAPS is a “thrombotic storm.” It is a state of extreme blood clotting (hypercoagulability) that causes widespread blockages in the smallest blood vessels (microvascular thrombosis) ^[3].

To be classified as “definite CAPS,” four specific criteria are generally met:

1. Multiple Organ Involvement: Evidence that at least three different organs, systems, or tissues are affected ^[3].
2. Rapid Progression: These symptoms develop simultaneously or within less than one week ^[3][4].
3. Small Vessel Blockage: Histopathologic (tissue biopsy) confirmation of clots in small blood vessels in at least one organ. However, patients who cannot safely undergo biopsy may be classified as probable CAPS or treated on clinical suspicion ^[5].
4. Antibody Confirmation: Lab tests showing the presence of antiphospholipid antibodies ^[3].

Recognizing the Emergency

CAPS moves with devastating speed. Because it affects the smallest vessels, it can damage multiple organs at once. You should call emergency services or go immediately to the nearest emergency department if a person with APS—or anyone experiencing rapid, unexplained illness—shows these early warning signs of multiorgan failure:

• Brain: Sudden confusion, seizures, or signs of a stroke (weakness, slurred speech) ^[6][7].
• Lungs: Severe shortness of breath (dyspnea) or coughing up blood ^[6].
• Kidneys: A sudden drop in urine output or dark-colored urine ^[6].
• Heart: Chest pain, rapid heart rate, or signs of heart failure ^[6].
• Skin: Painful purple skin patterns (livedo reticularis), skin ulcers, or areas of black, dying tissue (necrosis) ^[8][6].

A falling platelet count (cells that help blood clot) is a common clue requiring urgent clinician evaluation, though it can drop for many other reasons ^[9].

Why Does This Happen?

In registry data, an identified event “triggers” the immune system to spiral out of control in about 65% of cases ^[7]. Identifying these triggers is a vital part of helping the medical team:

• Infections: These are the most common trigger, occurring in about 49% of triggered registry cases ^[7].
• Surgery or Trauma: Recent invasive procedures can provoke a systemic clotting response ^[10][11].
• Medication Changes: Stopping blood thinners or switching from a Vitamin K Antagonist (like warfarin) to a Direct Oral Anticoagulant (DOAC) has been associated with some cases ^[10][12].
• Pregnancy/Postpartum: The period during or immediately after pregnancy is a high-risk window for CAPS ^[10][13].

Immediate Steps for Caregivers

If you suspect CAPS, every minute matters. Medical guidelines state that if suspicion is high, treatment should not be delayed for biopsies or waiting on test results ^[11][3].

1. Communicate History: Immediately tell the ER or ICU team if the patient has a known history of APS or Systemic Lupus Erythematosus (SLE) ^[7].
2. Report Triggers: Tell the doctors about any recent infections, skipped doses of blood thinners, or recent surgeries.
3. Request Specialists: Ask for a consultation with a hematologist (blood specialist) or rheumatologist (immune specialist) who is familiar with CAPS.
4. Discuss “Triple Therapy”: Standard treatment typically involves a combination of three things: intensive blood thinning (anticoagulation), high-dose steroids to calm the immune system, and “cleaning” the blood through plasma exchange or IVIG (intravenous immunoglobulin) ^[11][4].

While the mortality rate was historically 50%, modern intensive care and “triple therapy” protocols have reduced this significantly, with more recent studies reporting survival rates of 70–75% ^[7][14]. Do not try to transfer the patient yourself; let the treating team arrange specialist consultation or transfer if needed.